$28.49
0.833%
Últ. Act.: Nov 6, 4:00 PM
The average analyst price target for Amphastar Pharma is $28.75, 0.9% above the current price. Of 5 analysts, 4 rate it Hold and 1 Sell. Targets range from $20 to $55. The latest change came on Nov 6, 2026, when Wells Fargo raised its price target on Amphastar Pharma from $20 to $25 and kept an Equal-Weight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months